India Yugal Sikri, chairman of the Pharmaceutical Management Program of the prestigious NMIMS University, and with an extremely rich experience in the pharmaceutical industry, explains his mission to build a valuable discussion platform for CEOs and institutions of the industry alike. Such industry efforts will ensure the Indian pharmaceutical industry efficiently…
Portugal Oscar Gaspar, VP of the Confederation of Portuguese Industry (CIP), president of the Portuguese Association of Private Hospitalization and former secretary of state for health (2009-2011), provides an informative insight into the state of Portugal’s healthcare system. Through compelling suggestions and observations on the current system, Gaspar sheds light on…
UK Recipient of the 2018 Brain Prize for research for groundbreaking research on the generic and molecular basis of Alzheimer’s Disease, the UCL’s Professor John Hardy discusses recent progress in dementia research, the strengths and weaknesses of the UK’s medical research environment, and the potential effects of Brexit. In all…
Ecuador Tania Mori Lucero, executive director of the Ecuadorian National Institute of Public Research (INSPI), details the entity’s role in supporting the elaboration of public health policies under the Ministry of Public Health’s umbrella. Mori highlights the important progress that has been made in the country’s research ecosystem and documents the…
UK British consultant, speaker and author, Richard Barker – a key opinion leader on UK healthcare – gives his take on the recently launched ‘Life Sciences Industrial Strategy’, the importance of facilitating accelerated access to medicines, and the potential fallout from Brexit to the UK’s life sciences ecosystem. On the…
Ecuador Angel Guevara, molecular biologist and professor at the Central University of Ecuador (UCE), discusses Ecuador’s potential as a clinical trial destination, a diverse tropical country with high prevalence of infectious disease and educated healthcare professionals. He explains the differences between public and private healthcare services, notably from the point of…
Lithuania Zydrune Visiockene, head of Vilnius University’s Center of Endocrinology and a key opinion leader on the topic of diabetes in the Baltics, casts his expert eye over the disease’s prevalence in Lithuania as well as the private and public sector initiatives currently underway to counter this important public health threat.…
Tunisia Hatem Hachicha is Pfizer’s former manager for Tunisia, Libya and French-speaking African countries. He believes Tunisia’s pharmaceutical industry development will be achieved through internationalization and a shift towards biosimilars drugs. Co-founder of SEPHIRE and an active member of the Tunisian healthcare community, he stresses that one of the challenges in…
Taiwan Dr. Hui-Ting Huang, President of Taiwan Adventist Hospital, discusses the challenges of long-term care and the role preventive medicine plays within this scope, while also providing insights on running one of the most recognized hospitals in Taiwan and establishing a different business model through health promotion. Dr. Huang you were…
Ireland Jack Daly, Commercial Manager at IMS Health Ireland, discusses the strategic decision of IMS Health to diversify into the health consultancy space, the importance of developing long-term partnerships with clients instead of transactional interactions, and the most important trends he sees in the Irish market today. To begin, could you…
Luxembourg Rudi Balling discusses his distinguished career in the life sciences, the LCSB’s mission, and Luxembourg’s burgeoning reputation as a biomedicine, interdisciplinary research, and scientific innovation hub. Earlier this year you were awarded the ‘Ordre de Mérite’ for your longstanding contribution to science by the Luxembourg government following a distinguished career…
Mexico Dr. David Kershenobich Stalnikowitz, General Director of the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán on the myriad issues surrounding diabetes in Mexico and how the Mexican healthcare system can evolve. You have highlighted the importance of the institute operating as a reference center. What have been some…
See our Cookie Privacy Policy Here